Ipca Laboratories Limited
Records under this name other than the patents Ipca Laboratories Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Ipca Laboratories Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,541,422 | Methods for the treatment or prophylaxis of thrombosis or embolism Lapsed on the fee record Ended Sep 24, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 24, 2025 | From the USPTO record |
| US 8,536,337 | Solid forms of methyl (7aS,2′S)-2-(2-chlorophenyl)-2-(2,4,5,6,7,7a-hexahydrothieno[3,2-c]-5-pyridin-2-one)acetate Lapsed on the fee record Ended Sep 17, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 17, 2025 | From the USPTO record |
| US 9,492,406 | Pharmaceutical composition Lapsed on the fee record Ended Nov 15, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 15, 2024 | From the USPTO record |
| US 9,321,785 | Methods for the treatment or prophylaxis of thrombosis or embolism Lapsed on the fee record Ended Apr 26, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2024 | From the USPTO record |
| US 7,847,127 | Process for preparation of atovaquone and novel intermediates thereof Lapsed on the fee record Ended Dec 7, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 7, 2022 | From the USPTO record |
| US 10,105,353 | Anti-thrombotic compounds Lapsed on the fee record Ended Oct 23, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 23, 2022 | From the USPTO record |
| US 7,629,465 | Industrial process for preparation of Clopidogrel hydrogen sulphate Lapsed on the fee record Ended Dec 8, 2017 · From the USPTO record | Lapsed on the fee record | Ended Dec 8, 2017 | From the USPTO record |
| US 7,547,791 | One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O Lapsed on the fee record Ended Jun 16, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jun 16, 2017 | From the USPTO record |
| US 8,415,360 | Pharmaceutical compositions for the treatment of diabetes mellitus Lapsed on the fee record Ended Apr 9, 2017 · From the USPTO record | Lapsed on the fee record | Ended Apr 9, 2017 | From the USPTO record |
| US 7,459,467 | Manufacturing process for methyl phenidate and intermediates thereof Lapsed on the fee record Ended Dec 2, 2016 · From the USPTO record | Lapsed on the fee record | Ended Dec 2, 2016 | From the USPTO record |